FAQs
Which studies are done or on-going with DC Beads?
| PRECISION I | Barcelona | Dose, Safety, Response | HCC | 28 |
|---|---|---|---|---|
| PRECISION II | Hong Kong | Dose, Safety, Response | HCC | 33 |
| PRECISION I + PRECISION II |
||||
| PRECISION IV* | Multi-Centre US | RCT - Survival | HCC | 400 |
| PRECISION V | Multi-Centre EU | RCT - Tumour Response, QOL, $ | HCC | 200 |
| PRECISION VI | Single Centre | Safety and efficacy | Lung cancer | 20 |
| Dr Geschwind | Hopkins, USA | Safety (+effectiveness) | HCC | 10+ |
| HEP-1 | Multi-Centre UK | RCT-Survival | HCC | 180 |
| Professor Lammer | Austria | Response & Survival | HCC | 30 |
* Not initiated –BCP in discussion with The National Cancer Institute (NCI) forfunding
In this section
Disclaimer
The products may not be available for sale, may not be registered, approved or cleared for use as claimed, in all countries where Biocompatibles is represented.